Does extended-release somatostatin slow the growth of renal cysts in autosomal-dominant polycystic kidney disease?

Nat Clin Pract Nephrol. 2006 Feb;2(2):66-7. doi: 10.1038/ncpneph0082.
No abstract available

MeSH terms

  • Delayed-Action Preparations / therapeutic use
  • Humans
  • Polycystic Kidney, Autosomal Dominant / prevention & control*
  • Somatostatin / therapeutic use*

Substances

  • Delayed-Action Preparations
  • Somatostatin